On thalidomide and WHO policies.
Ministry of Health, Brazil.
G F M
GF
Pereira
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D014943:Global Health; D006291:Health Policy; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects*; D007918:Leprosy / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*; D014944:World Health Organization
D007917:Leprostatic Agents; D013792:Thalidomide